QLQ-CAX24 Phase4

Project

QLQ-CAX24 Phase4

Automatically Closed · 2017 until 2017

Strasser Florian, Domeisen Benedetti Franzisca, Attoun-Knobel Suzanne

Type

Clinical Studies

Range

Multicentric, KSSG as participating partner

Units

Zentrum für Integrative Medizin, Palliativzentrum, Medizinische Onkologie und Hämatologie

Status

Automatically Closed

Start Date

2017

End Date

2017

Financing

Others

Study Design

The primary study objective is to test the scale structure, reliability, responsiveness to change and validity of the EORTC QLQ-CAX24 in conjunction with the EORTC QLQ-C30 in people diagnosed with cancer cachexia with different primary cancer diagnoses, at different stages of disease, and with different amount of secondary nutrition impact symptoms.

Brief description/objective

The aim of the present study is to test the scale structure, reliability, responsiveness to change and validity of the EORTC QLQ-CAX24 in conjunction with the EORTC QLQ-C30 in people diagnosed with cancer cachexia with different primary cancer diagnoses, at different stages of disease, and with different amount of secondary nutrition impact symptoms (S-NIS). N=240-360 patients with cachexia syndrome (Group A), n=240-360 patients with refractory cachexia (Group B) and n=50 patients with weight loss <2% (Group C) will be recruited.